Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients

Sercan YİLMAZ; Halil Çağrı AYBAL; Hakan ÖZDEMİR; Eymen GAZEL; Mehmet YILMAZ; Engin KAYA; Serdar YALÇIN; Ali ONER; Mehmet YORUBULUT; Lütfi TUNÇ

doi:https://doi.org/10.33719/yud.2021;16-2-850577

Article Details

Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients

Authors:

Sercan YİLMAZ | Halil Çağrı AYBAL | Hakan ÖZDEMİR | Eymen GAZEL | Mehmet YILMAZ | Engin KAYA | Serdar YALÇIN | Ali ONER | Mehmet YORUBULUT | Lütfi TUNÇ

Publisher:

Ali İhsan TAŞÇI

Main Topics:

Diseases

Journal:

The New Journal of Urology 2021 Vol.16 Issue 2, pp.140-147

Document Type:

Article

Publication Date:

6/2021

Document Language:

English

Document ID (Org No.):

2000696923

Frequency:

Tri-annual

eISSN:

2687-1955

pISSN:

1305-2489

DOI:

https://doi.org/10.33719/yud.2021;16-2-850577

Abstract:

 


Objective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and compare with current literature. 

Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men were retrospectively analyzed. PI-RADS scores were determined as 3, 4 and 5 in 222 (62%), 107 (29.8%) and 29 (8.1%) patients, respectively. Totally 454 lesions were underwent  MRI-US FPBx. 303 (66.7%) lesions were scored as PI-RADS 3, 120 (26.4%) lesions were scored as PI-RADS 4 and 31 (6.8%) lesions were scored as PI-RADS 5. 315 (69.3%) of lesions were in peripheral zone, 26 (5.7%) were in central zone, 111 (24.4%) were in transitional zone and 2 of them were in anterior fibromuscular stroma.

Results: Overall prostate cancer detection rate was 36.3%. Concerning detection rates, MRI-US FPBx alone and transrectal ultrasonography guided prostate biopsy (TRUS-Bx) alone were 27.6% and 26.5%,  respectively. Cancer detection rate only through MRI-US FPBx PIRADS-3 and PI-RADS 4&5 were 6.9% and 20.6%, respectively. Clinically significant prostate cancer (csPCa) rates were evaluated and csPCa to overall prostate cancer (PCa) rates for TRUS-Bx, MRI-US FPBx and combined techniques were 16.8%, 35.4% and 39.2%, respectively. Results of 11 patients were evaluated as benign.

 
Conclusion: MRI-US FPBx significantly increases success rate of prostate biopsy procedure. Regarding current MRI technology, it is not appropriate to consider MRI-US FPBx as a stand-alone biopsy option without concomitant with TRUS-Bx.

.

 


Amaç: Çalışmamızda tek merkeze ait  manyetik rezonans görüntüleme-ultrason  füzyon prostat biyopsisi (MRI-US FPBx ) sonuçlarını değerlendirmek ve güncel literatürle karşılaştırmak istedik.


Gereç ve Yöntemler:: Ocak 2016 ile Temmuz 2019 arasında 358 erkeğin MRI-US FPBx sonuçları retrospektif olarak analiz edildi. PI-RADS skorları 222 (% 62), 107 (% 29.8) ve 29 (% 8.1) hastada sırasıyla 3, 4 ve 5 olarak tespit edildi. Toplam 454 lezyona MRI-US FPBx uygulandı. 303 (% 66,7) lezyon PI-RADS 3, 120 (% 26,4) lezyon PI-RADS 4 ve 31 (% 6,8) lezyon PI-RADS 5 olarak skorlandı. Lezyonların 315'i (% 69,3) periferik zonda, 26'sı (% 5,7) santral zonda, 111'i (% 24,4) geçiş zonu ve 2'si anterior fibromüsküler stromada idi.


Bulgular: Genel prostat kanseri (PCa) tespit oranı% 36.3 idi. Tek başına MRI-US FPBx ve tek başına transrektal ultrasonografi eşliğinde prostat biyopsisi (TRUS-Bx) kanser saptama oranları sırasıyla % 27.6 ve% 26.5 idi. PI-RADS-3 ve PI-RADS 4 & 5 için MRI-US FPBx'e özgü kanser tespit oranı sırasıyla % 6,9 ve% 20,6 idi. Klinik olarak önemli prostat kanseri (csPCa) oranları değerlendirildi ve TRUS-Bx, MRI-US FPBx ve kombine teknikler için csPCa ve PCa oranları sırasıyla % 16.8, % 35.4 ve % 39.2 idi. 11 hastanın biyopsi sonuçları benigndi. 


Sonuç: MRI-US FPBx , prostat biyopsi prosedürünün başarı oranını önemli ölçüde artırır. Ancak mevcut MRI teknolojisine göre, MRI-US FPBx'i TRUS-Bx  olmaksızın bağımsız bir biyopsi seçeneği olarak düşünmek uygun olmadığı görüşündeyiz.

.

Article Details

Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients

Authors: Sercan YİLMAZ | Halil Çağrı AYBAL | Hakan ÖZDEMİR | Eymen GAZEL | Mehmet YILMAZ | Engin KAYA | Serdar YALÇIN | Ali ONER | Mehmet YORUBULUT | Lütfi TUNÇ

Publisher: Ali İhsan TAŞÇI

Main Topics: Diseases

Journal: The New Journal of Urology 2021 Vol.16 Issue 2, pp.140-147

Document Type: Article

Publication Date: 6/2021

Document Language: English

Document ID (Org No.): 2000696923

Frequency: Tri-annual

eISSN: 2687-1955

pISSN: 1305-2489

DOI: https://doi.org/10.33719/yud.2021;16-2-850577

Issues

Authors:

Sercan YİLMAZ | Halil Çağrı AYBAL | Hakan ÖZDEMİR | Eymen GAZEL | Mehmet YILMAZ | Engin KAYA | Serdar YALÇIN | Ali ONER | Mehmet YORUBULUT | Lütfi TUNÇ

Publisher:

Ali İhsan TAŞÇI

Main Topics:

Diseases

Journal:

The New Journal of Urology 2021 Vol.16 Issue 2, pp.140-147

Document Type:

Article

Publication Date:

6/2021

Document Language:

English

Document ID (Org No.):

2000696923

Frequency:

Tri-annual

eISSN:

2687-1955

pISSN:

1305-2489

DOI:

https://doi.org/10.33719/yud.2021;16-2-850577